Stock Forums › Stocks Forum › Nasdaq Stocks › REGN – Regeneron Pharmaceuticals, Inc.
Tagged: Regeneron Pharmaceuticals, REGN
This topic contains 2 replies, has 1 voice, and was last updated by Stocks News Feed 2 months, 1 week ago.
REGN – Regeneron Pharmaceuticals Inc closed down about 7% after earnings report.
The company earned $4.45 per share on total revenues of $1.712 billion. Analysts had been expecting earnings of $5.52 per share on revenue of $1.76b.
REGN: FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents
Done Reading? You might also find these links useful:
Stock Market News | Social Activity Stream | Stock Forums
Enter your email address to subscribe to StocksNewsFeed newsletter and receive notifications by email.